Who has invested in InterCure?

Nippon Venture Capital, Bennu Pharma Fund Ltd. are named among the investors backing InterCure.

InterCure Funding: $7.4M Raised, Investors & Rounds

InterCure funding overview

InterCure is based in Herzliya, Israel. InterCure has raised $7.4M in total disclosed funding. That places its disclosed total in the $1M–$25M range. The round record for InterCure runs through 2026; nothing later has been disclosed. Investors on record include Nippon Venture Capital, Bennu Pharma Fund Ltd.. 2 distinct backers are named across the disclosed rounds.

InterCure at a glance

Total raised: $7.4M
Latest round date: June 2026
Headquarters: Herzliya, Israel
Notable investors: Nippon Venture Capital, Bennu Pharma Fund Ltd.

Frequently asked about InterCure funding

How much has InterCure raised?: InterCure has raised $7.4M in total disclosed funding across the rounds on record.
Who has invested in InterCure?: Nippon Venture Capital, Bennu Pharma Fund Ltd. are named among the investors backing InterCure.
What was the latest InterCure funding round?: No round stage has been disclosed for InterCure.
Where is InterCure based?: InterCure is based in Herzliya, Israel.
When did InterCure last raise?: The last disclosed InterCure round closed in June 2026.

InterCure totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Herzliya below to benchmark round size and investor mix.

InterCure Funding: $7.4M Raised, Investors & Rounds

InterCure funding overview

InterCure at a glance

Frequently asked about InterCure funding

Companies related to InterCure (14)

Browse related funding lists (2)